Viropro Stock Analysis

Viropro Stock Analysis Notes

The company has Price to Book (P/B) ratio of 1.17. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Viropro had not issued any dividends in recent years. The entity had 1:12.14 split on the 26th of November 2003. Viropro Inc., through its subsidiaries, engages in the contract research, development, and manufacture of biotherapeutic proteins for the treatment of various diseases. Viropro Inc. has collaboration agreement with Oncobiologics, Inc. to manufacture and commercialize monoclonal antibody products. VIROPRO INC operates under Biotechnology classification in the United States and is traded on PNK Exchange. For more information please call Michelle Peake at 650 300 5190 or visit https://www.viropro.net.

Viropro Investment Alerts

Viropro Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 18.32 K.

Viropro Profitablity

Management Efficiency

As of the 28th of December 2025, Return On Tangible Assets is likely to drop to -4.04. In addition to that, Return On Capital Employed is likely to grow to -0.58. At this time, Viropro's Total Assets are very stable compared to the past year. As of the 28th of December 2025, Fixed Asset Turnover is likely to grow to 16.32, while Net Tangible Assets are likely to drop (508.4 K). Viropro's management efficiency ratios could be used to measure how well Viropro manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viropro, as well as the relationship between them.

Viropro Price Movement Analysis

Viropro Insider Trading Activities

Viropro Outstanding Bonds

Stock analysis is the technique used by a trader or investor to examine and evaluate how Viropro prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Viropro shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Viropro. By using and applying Viropro Stock analysis, traders can create a robust methodology for identifying Viropro entry and exit points for their positions.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viropro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Viropro Stock, please use our How to Invest in Viropro guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Viropro. If investors know Viropro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Viropro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Viropro is measured differently than its book value, which is the value of Viropro that is recorded on the company's balance sheet. Investors also form their own opinion of Viropro's value that differs from its market value or its book value, called intrinsic value, which is Viropro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Viropro's market value can be influenced by many factors that don't directly affect Viropro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Viropro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viropro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Viropro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.